Gilead Sciences, Inc.
Processes and intermediates for preparing MCL1 inhibitors
Last updated:
Abstract:
The present disclosure provides methods for preparing MCL1 inhibitors or a salt thereof and related key intermediates.
Status:
Grant
Type:
Utility
Filling date:
20 Nov 2020
Issue date:
10 May 2022